Ignite Creation Date:
2025-12-24 @ 1:42 PM
Ignite Modification Date:
2026-07-17 @ 6:05 AM
Study NCT ID:
NCT06563895
Status:
RECRUITING
Last Update Posted:
2025-12-23
First Post:
2024-08-05
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
Sponsor:
Eidos Therapeutics, a BridgeBio company
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
AG10-501
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None